Perpetual Ltd’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
MCI
Perpetual Ltd's REGN Position: Q3 2026 in Review
Perpetual Ltd reduced its Regeneron Pharmaceuticals (REGN) stake by 66% in Q3 2026, selling an estimated $1.21M and leaving 809 shares worth $613K. The position accounts for 0.01% of the portfolio, ranked #283.
Perpetual Ltd first reported a position in REGN in Q3 2016 and has held it in 18 quarters since. The position peaked at $100M in Q1 2023. 656 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Perpetual Ltd held 809 shares of Regeneron Pharmaceuticals worth $613K as of Q3 2026.
- Perpetual Ltd sold 1,598 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $1.21M.
- Regeneron Pharmaceuticals made up 0.01% of Perpetual Ltd's portfolio in Q3 2026, its #283 holding.
- Perpetual Ltd first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 18 quarters since.
- Perpetual Ltd's Regeneron Pharmaceuticals position peaked at $100M in Q1 2023.
- 656 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.